Evotec SE (EVO) Operating Income (2009 - 2025)
Evotec SE's (EVO) quarterly Operating Income came in at $44000.8 in Q4 2025, up 635.29% year-over-year from $5984.1 in Q4 2024, and up 100.08% quarter-over-quarter from -$52.0 million in Q3 2025.
Analysis
Evotec SE (EVO) Operating Income (2009 - 2025) Analysis & Trends
Evotec SE has disclosed Operating Income across 9 years of filings, most recently posting $44000.8 for Q4 2025.
- In Q4 2025, Operating Income rose 635.29% year-over-year to $44000.8; the TTM figure through Dec 2025 stood at -$104.5 million (up 35.32% YoY), while the FY2025 annual figure was -$84170.9, up 99.95% from the prior year.
- Operating Income came in at $44000.8 for Q4 2025 at Evotec SE, up from -$52.0 million in the prior quarter.
- In the past five years, Operating Income ranged from a high of $46.9 million in Q4 2021 to a low of -$112.6 million in Q2 2024.
- Average Operating Income over 5 years is -$14.3 million, with a median of -$2.0 million recorded in 2022.
- Year-over-year, Operating Income tumbled 225149.22% in 2023 and surged 635.29% in 2025.
- Over 5 years, Operating Income stood at $46.9 million in 2021, then sank by 100.04% to -$17176.9 in 2022, then plunged by 225149.22% to -$38.7 million in 2023, then surged by 100.02% to $5984.1 in 2024, then surged by 635.29% to $44000.8 in 2025.
- Per Business Quant data, the three most recent Operating Income figures were $44000.8 in Q4 2025, -$52.0 million in Q3 2025, and -$31.4 million in Q2 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Iqvia Holdings | 42.77 Bn | 40.69 Bn | 1.44 Bn | 506.00 Mn |
| 2 | Medpace Holdings | 16.50 Bn | 16.00 Bn | 201.64 Mn | 146.82 Mn |
| 3 | Charles River Laboratories International | 13.37 Bn | 13.18 Bn | 452.07 Mn | 119.89 Mn |
| 4 | Icon | 12.49 Bn | 11.56 Bn | 479.29 Mn | 137.83 Mn |
| 5 | Fortrea Holdings | 1.58 Bn | 1.42 Bn | 139.20 Mn | 14.80 Mn |
| 6 | Evotec SE | 642.83 Mn | 216.96 Mn | - | - |
| 7 | Ginkgo Bioworks Holdings | 422.55 Mn | 338.02 Mn | 18.44 Mn | -58.55 Mn |
| 8 | Champions Oncology | 69.16 Mn | 69.16 Mn | 7.03 Mn | -522,000.00 |
| 9 | MindWalk Holdings | 59.83 Mn | 51.55 Mn | 1.82 Mn | -3.16 Mn |
| 10 | VivoSim Labs | 1.45 Mn | 1.45 Mn | - | -2.76 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 44,000.84 |
| Sep 30, 2025 | -52.03 Mn |
| Jun 30, 2025 | -31.44 Mn |
| Mar 31, 2025 | -21.05 Mn |
| Dec 31, 2024 | 5,984.13 |
| Sep 30, 2024 | -29.10 Mn |
| Jun 30, 2024 | -112.65 Mn |
| Mar 31, 2024 | -19.78 Mn |
| Dec 31, 2023 | -38.69 Mn |
| Jun 30, 2023 | -39.51 Mn |
| Dec 31, 2022 | -17,176.88 |
| Sep 30, 2022 | 13.64 Mn |
| Jun 30, 2022 | -4.02 Mn |
| Mar 31, 2022 | 519,642.36 |
| Dec 31, 2021 | 46.90 Mn |
| Sep 30, 2021 | 20.92 Mn |
| Jun 30, 2021 | 1,850.97 |
| Mar 31, 2021 | 8.18 Mn |
| Dec 31, 2020 | 57.85 Mn |
| Sep 30, 2020 | 19.12 Mn |